Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating slow-release hydromorphone hydrochloride for osteoarthritis of the hip and knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Slow Release Hydromorphone HCl (hydromorphone hydrochloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Osteoarthritis, Hip, Osteoarthritis, Knee | Phase 3 | Status: COMPLETED